Chinese Distributor Of Counterfeit Pharmaceuticals Sentenced To Prison For 78 Months, $1.286 Million In Restitution To Pfizer And Lilly
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The 5th Circuit U.S. Court of Appeals re-sentenced Kevin Xu, owner of Pacific Orient International, a pharmaceutical distributor in China, to prison for conspiring to distribute counterfeit and misbranded drugs, United States Attorney José Angel Moreno announced April 23
You may also be interested in...
IFPMA Outlines Plan For Fighting Counterfeit Drugs
HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem
IFPMA Outlines Plan For Fighting Counterfeit Drugs
HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem
China's SFDA Launches Inspection Campaign To Ferret Out Fake Drugs Sold In Retail Outlets
SHANGHAI - China's State FDA together with the Ministry Of Health launched nationwide inspections this month in retail pharmacies to sweep out non-pharmaceutical products that are marketed as medicines, the agency announced Nov. 11